Zobrazeno 1 - 10
of 4 798
pro vyhledávání: '"Wu Chou"'
Autor:
Chun-Hua Hung, Shang-Yin Wu, Cheng-I Daniel Yao, Hsuan-Heng Yeh, Chien-Chung Lin, Chang-Yao Chu, Tzu-Yu Huang, Meng-Ru Shen, Chun-Hung Lin, Wu-Chou Su
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-24 (2024)
Abstract The IL6-GP130-STAT3 pathway facilitates lung cancer progression and resistance to tyrosine kinase inhibitors. Although glycosylation alters the stability of GP130, its effect on the ligand IL6 remains unclear. We herein find that N-glycosyla
Externí odkaz:
https://doaj.org/article/3a5cd2f7ff2f4570954e24e9d5764b19
Autor:
Harrell, Stevan
Publikováno v:
Pacific Affairs, 2017 Mar 01. 90(1), 218-220.
Externí odkaz:
https://www.jstor.org/stable/44876191
Erdafitinib in Asian patients with advanced solid tumors: an open-label, single-arm, phase IIa trial
Autor:
Joon Oh Park, Yin-Hsun Feng, Wu-Chou Su, Do-Youn Oh, Bhumsuk Keam, Lin Shen, Sang-We Kim, Xiufeng Liu, Huimin Liao, Min Qing, Chong Zhang, Jiaqi Qian, Xiaodan Tang, Peng Li, Spyros Triantos, Hussein Sweiti
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-13 (2024)
Abstract Background FGFR genomic aberrations occur in approximately 5–10% of human cancers. Erdafitinib has previously demonstrated efficacy and safety in FGFR-altered advanced solid tumors, such as gliomas, thoracic, gastrointestinal, gynecologica
Externí odkaz:
https://doaj.org/article/46cf37a8f4c5475998d9519b116a314e
Autor:
Michael Boyer, Rina Hui, Damien Urban, Philip Clingan, Wu-Chou Su, Celine Devaux, Shirish Gadgeel, Marina Garassino, Lance Leopold, Jeannie Daniel, Mihaela C. Munteanu, Ayman Samkari, Yiwen Luo, Delvys Rodriguez Abreu
Publikováno v:
BMC Cancer, Vol 23, Iss S1, Pp 1-12 (2024)
Abstract Background The combination of the checkpoint inhibitor (CPI) pembrolizumab and platinum-based chemotherapy is effective frontline therapy for advanced non-small cell lung cancer (NSCLC) lacking targetable mutations. Indoleamine 2,3- dioxygen
Externí odkaz:
https://doaj.org/article/f859d06395444ff68173b8d586898c31
Autor:
Lin, Yi-Rong (AUTHOR), Lin, Wu-Chou (AUTHOR), Wu, Mei-Yao (AUTHOR), Lin, Cheng-Li (AUTHOR), Yang, Su-Tso (AUTHOR), Yen, Hung-Rong (AUTHOR)
Publikováno v:
International Journal of Women's Health. Aug2024, Vol. 16, p1361-1375. 15p.
Autor:
Bin-Chi Liao, Nai-Jung Chiang, Gee-Chen Chang, Wu-Chou Su, Yung-Hung Luo, Inn-Wen Chong, Tsung-Ying Yang, Chun-Liang Lai, Te-Chun Hsia, Ching-Liang Ho, Kang-Yun Lee, Chin-Fu Hsiao, Fan-Chen Ku, Wei-Tse Fang, James Chih-Hsin Yang
Publikováno v:
JCO Global Oncology, Iss 10 (2024)
PURPOSETissue-based next-generation sequencing (NGS) analysis is highly recommended for patients with advanced/metastatic non–small cell lung cancer (NSCLC). We investigated a specific patient population with NSCLC that required tissue-based NGS an
Externí odkaz:
https://doaj.org/article/e503bb76a5e74e31a0d489729debaa21
Publikováno v:
International Journal of Infectious Diseases, Vol 146, Iss , Pp 107119- (2024)
The ascomycete filamentous fungus Neurospora intermedia is commonly used in the food industry and considered nonpathogenic to humans. This study characterizes four N. intermedia isolates recovered from three patients. The first patient had a mediasti
Externí odkaz:
https://doaj.org/article/a4dc25e20bf9496db9d6653f9e39c51e
Autor:
You-En Yang, Meng-Hsuan Hu, Yen-Chen Zeng, Yau-Lin Tseng, Ying-Yuan Chen, Wu-Chou Su, Chih-Peng Chang, Yi-Ching Wang
Publikováno v:
Cell Death and Disease, Vol 15, Iss 5, Pp 1-13 (2024)
Abstract IL-33 is a danger signal that binds to its receptor ST2L to promote tumor progression. This study identifies the IL-33/ST2L positive-feedback loop and the trafficking of ST2L membrane presentation in macrophages that contribute to lung tumor
Externí odkaz:
https://doaj.org/article/5eb3ecf778c04b50bdc1a72f3fada202
Autor:
Jia, Shaobo, Zhu, Haiyan, Cao, Rong, Wu, Qi, Wu, Chou, Zhou, Qiangqiang, Liu, Ping, Li, Baiyue, Li, Anyang, Li, Yawei
Publikováno v:
In International Journal of Hydrogen Energy 19 September 2024 83:367-377
Publikováno v:
In Sensors and Actuators: B. Chemical 15 January 2025 423